Metraipolis › archive › dc_7b4aaa0b35e5
Fundamentals and emerging frontiers in p53-targeted drug development — Europe PMC PMID:42306789
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42306789
- DOI
- 10.1016/j.bbrep.2026.102661
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T19:52:58.412Z
- SHA-256 of the archived text
375ef89a58e5553d10b6a08e75287b8063e0480990c22f3b439ac3343b94ecf3- Stable URL of this page
https://metraipolis.com/documento/dc_7b4aaa0b35e5
How to cite
Fundamentals and emerging frontiers in p53-targeted drug development — Europe PMC PMID:42306789 — Europe PMC (en), https://europepmc.org/article/MED/42306789 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b4aaa0b35e5 (Metraipolis archive dc_7b4aaa0b35e5, sha256 375ef89a58e5553d10b6a08e75287b8063e0480990c22f3b439ac3343b94ecf3)
BibTeX
@misc{dc7b4aaa0b35e5,
title = {Fundamentals and emerging frontiers in p53-targeted drug development — Europe PMC PMID:42306789},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42306789},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b4aaa0b35e5; sha256 375ef89a58e5553d10b6a08e75287b8063e0480990c22f3b439ac3343b94ecf3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306789. Agents can read the archived copy with the MCP tool read_document.